Objectives

Through this project, WCC will support children throughout their journey so that:

• more children can be diagnosed, and earlier, thanks to raising awareness of signs and symptoms among healthcare professionals at primary care level
• barriers to equitable access, and adherence, to treatment are addressed
• an enabling healthcare system is created to strengthen the speed and accuracy of diagnosis of Burkitt lymphoma (BL), to strengthen the capacity of healthcare professionals to use rituximab in a safe and effective manner and to provide the necessary supportive care, to manage emergencies and avoid complications among others
• children and their families receive the emotional and educational support they need to not only survive but thrive and inspire hope in others starting their cancer journey
• we gather evidence and share learning to improve policy and practice including through publications and at conferences, on the benefits of improving access to cancer targeted drugs for pediatric oncology in LMICs. This will underpin advocacy objectives with governments, the WHO, and other key stakeholders and policymakers